Product Description for EIG121
Properties: (C-term) Control Peptide
Properties for EIG121
|Product Category||Control Peptides|
|PDF datasheet||View Datasheet|
|Manufacturer||Acris Antibodies GmbH|
|Material safety datasheet||MSDS for Polyclonal Antibodies (de)|
The peptide is used for blocking the activity of EIG121 antibody Cat.-No. AP55541PU-N. It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37°C.
|General Readings||Deng L, Broaddus RR, McCampbell A, et al. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer. Clin. Cancer Res. 2005; 11:8258-64.|
Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.